Chao Wen Lai
Directeur/Membre du Conseil chez Cyagen Suzhou Biosciences Technology Co., Ltd.
Profil
Chao Wen Lai has a current job as a Member-Supervisory Board at Cyagen Suzhou Biosciences Technology Co., Ltd.
Postes actifs de Chao Wen Lai
| Sociétés | Poste | Début |
|---|---|---|
Cyagen Suzhou Biosciences Technology Co., Ltd.
 Cyagen Suzhou Biosciences Technology Co., Ltd. BiotechnologyHealth Technology Cyagen Suzhou Biosciences Technology Co., Ltd. specializes in producing custom-engineered mouse and rat models, as well as providing services such as viral packaging, vector cloning, stem cells, and cell culture reagents. The company is based in Taicang, China and was founded in 2011. Cyagen is known for its top-quality services, full guarantee, and competitive prices. The Chinese company also offers mouse embryo and sperm cryopreservation services to protect valuable strains and reduce costs. The protein encoded by the rag2 gene is critical for v(d)j recombination during B and T cell maturation, and Cyagen's services have become well-known for their role in this process. The CEO is Lan Qing Han. | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Cyagen Suzhou Biosciences Technology Co., Ltd.
Cyagen Suzhou Biosciences Technology Co., Ltd. BiotechnologyHealth Technology Cyagen Suzhou Biosciences Technology Co., Ltd. specializes in producing custom-engineered mouse and rat models, as well as providing services such as viral packaging, vector cloning, stem cells, and cell culture reagents. The company is based in Taicang, China and was founded in 2011. Cyagen is known for its top-quality services, full guarantee, and competitive prices. The Chinese company also offers mouse embryo and sperm cryopreservation services to protect valuable strains and reduce costs. The protein encoded by the rag2 gene is critical for v(d)j recombination during B and T cell maturation, and Cyagen's services have become well-known for their role in this process. The CEO is Lan Qing Han. | Health Technology |
